Do Analysts Agree Friday on Agilon Health Inc (AGL) Stock's Target Price?

Friday, March 22, 2024 02:02 PM | InvestorsObserver Analysts

Mentioned in this article

Wall Street is positive on Agilon Health Inc (AGL). On average, analysts give the stock a Buy rating. The average price target is $10.718, which means analysts expect the stock to gain by 107.71% over the next twelve months. That average ranking earns the stock an Analyst Rating of 23, which is better than 23% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating AGL a Buy today. Find out what this means to you and get the rest of the rankings on AGL!
See Full AGL Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Agilon Health Inc Stock Today?

Agilon Health Inc (AGL) stock is down -5.06% while the S&P 500 is up 0.05% as of 1:48 PM on Friday, Mar 22. AGL has fallen -$0.27 from the previous closing price of $5.43 on volume of 1,264,147 shares. Over the past year the S&P 500 has risen 32.81% while AGL has fallen -81.83%. AGL lost -$0.48 per share the over the last 12 months. Click Here to get the full Stock Report for Agilon Health Inc stock.

Share this article:

Related Articles